Rise Advisors’s CryoPort CYRX Stock Holding History

Rise Advisors’s Portfolio CYRX Stock Details CYRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-82	Closed	-$777	–	436
2025 Q3	$777	Hold	82	–	–	﹤0.01%	1312
2025 Q2	$612	Buy	+82	New	+$509	﹤0.01%	1366

Other funds holding CYRX

CCM

Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

Rise Advisors's CYRX Position: Q4 2025 in Review

Rise Advisors sold out of CryoPort (CYRX) in Q4 2025, closing a stake of 82 shares — an estimated $777 sold.

Rise Advisors first reported a position in CYRX in Q2 2025 and held it in 2 quarters. The position peaked at $777 in Q3 2025. 172 funds tracked by Wall St. Rank hold CYRX as of Q4 2025.

Rise Advisors reported no remaining CryoPort position as of Q4 2025 after selling out during the quarter.
Rise Advisors sold 82 CryoPort shares in Q4 2025, an estimated $777.
Rise Advisors first reported a position in CryoPort in Q2 2025 and held it in 2 quarters.
Rise Advisors's CryoPort position peaked at $777 in Q3 2025.
172 funds tracked by Wall St. Rank held CryoPort as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.